SCHEMBL6908460

SCHEMBL6908460

CCCOC(=O)CN(C(=O)CC)c1cccc(OC(C)=O)c1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
CYP3A4 P08684 1/20 0.40
FAAH O00519 1/20 0.39
ACHE P22303 2/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPT P10636 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
KMT2A Q03164 2/20 0.36
MTNR1A P48039 7/20 0.36
MTNR1B P49286 7/20 0.36
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6909985 0.91 LMNA (0.47) LMNACYP3A4ACHEKDM4EMAPT
SCHEMBL6909991 0.90 CYP3A4 (0.42) LMNACYP3A4FAAHACHEKMT2A
SCHEMBL6904457 0.86 LMNA (0.43) LMNACYP3A4ACHEKDM4EKMT2A
SCHEMBL6905457 0.85 LMNA (0.38) LMNAKDM4EMAPTTDP1KMT2A
SCHEMBL6907387 0.84 LMNA (0.45) LMNACYP3A4ACHEKDM4EKMT2A
SCHEMBL6902209 0.83 ALOX15 (0.44) LMNACYP3A4FAAHACHEKMT2A
SCHEMBL6907787 0.83 LMNA (0.48) LMNACYP3A4ACHEKDM4EMAPT
SCHEMBL6906982 0.83 LMNA (0.44) LMNACYP3A4ACHEKDM4EKMT2A
SCHEMBL6905596 0.76 LMNA (0.45) LMNACYP3A4KDM4EMAPTTDP1
SCHEMBL6906728 0.76 TDP1 (0.44) LMNAKDM4ETDP1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US claimed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP claimed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US claimed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO claimed
US-6824786-B2 TOPICAL APPLYING COSMETIC YU RUEY J (US) 2004-11-30 US disclosed
EP-1455734-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES Yu, Ruey J., Dr. (US) 2004-09-15 EP disclosed
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives YU RUEY J (US) 2003-06-12 US disclosed
WO-2003045338-A1 COMPOSITIONS COMPRISING PHENYL-GLYCINE DERIVATIVES YU RUEY J (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030108496-A1 Compositions comprising phenyl-glycine derivatives GRHPR, ARL1, SUCLG1 LMNA 1347/4885CYP3A4 4050/4885FAAH 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.